Navigation Links
Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)
Date:7/17/2009

THOUSAND OAKS, Calif., July 17 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved revisions to the U.S. prescribing information for the epidermal growth factor receptor (EGFr) class of antibodies, including Vectibix((R)) (panitumumab). This decision follows the FDA's December 2008 Oncologics Drugs Advisory Committee (ODAC) meeting where the clinical utility of the KRAS gene as a predictive biomarker in patients with metastatic colorectal cancer (mCRC) treated with anti-EGFr antibody was discussed.

"We are pleased that the FDA has recognized the clinical importance of KRAS as a predictive biomarker for anti-EGFr antibody therapy," said Sean Harper, M.D., chief medical officer and head of Global Development at Amgen.

The INDICATION AND USAGE section of the prescribing information has been updated to include that retrospective subset analyses of metastatic colorectal cancer trials have not shown a treatment benefit for Vectibix in patients whose tumors had KRAS mutations in codon 12 or 13. Use of Vectibix is not recommended for the treatment of colorectal cancer with these mutations.

The CLINICAL STUDIES section of the prescribing information has been updated to reflect results from retrospective analyses across seven randomized clinical trials with agents in this class. This includes the first Phase 3 analysis that showed mCRC patients with mutated KRAS tumors do not respond to monotherapy with an EGFr-inhibiting antibody (the Vectibix "408" trial).

"With this label update, physicians can now eliminate anti-EGFr antibodies as a treatment option for patients with mutated KRAS tumors and redirect those patients to alternative therapi
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Amgen Appoints Rebecca M. Henderson to the Companys Board of Directors
2. 34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence
3. AUDIO from Medialink and Amgen: Experts Agree Infection in Cancer Patients Impacts Treatment Success
4. Amgen to Present at the Goldman Sachs Global Healthcare Conference
5. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
6. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
7. Amgen Highlights Data to Be Presented at ASCO
8. Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
9. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
10. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
11. Amgen Announces Webcast of 2009 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Mansfield, Texas (PRWEB) March 03, 2015 ... natural childbirth, announced today they now have over 130 ... Canada and 1 in Germany. In addition, the company ... joining their existing childbirth educator certification program . ... both mom and her birth partner. The practical information ...
(Date:3/3/2015)... SC (PRWEB) March 03, 2015 March 3, ... for the 200th episode. The episode was a unique one, ... fourth season, but because it featured two men who were ... car accident. At the beginning of the episode, Deierlein said ... times on my radio show, but I’m very excited that ...
(Date:3/3/2015)... Presale tickets for Madonna will be ready for purchase ... March 9, with Madonna tour tickets expected to sell out ... talented artist is a significant one for fans, and the ... Ticketability.com to browse the inventory of Madonna tickets at ... enjoy, the 2015 tour is expected to attract attention from ...
(Date:3/3/2015)... 2015 Venato, a secure cloud-based ... their flagship software solution now provides an automated ... uploaded to the National Healthcare Safety Network (NHSN). ... (CMS) require that hospitals submit healthcare personnel (HCP) ... than May 15 for each influenza season in ...
(Date:3/3/2015)... Chicago has long been known as a premier ... a level of basketball to Chicago that the world had ... his Chicago Bulls days in the 1990’s. His brilliance created ... This era also witnessed the birth and rise of Nike ... rich basketball culture, US Sports Camps seeks to meet an ...
Breaking Medicine News(10 mins):Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2Health News:US Sports Camps and Nike Basketball Camps Add Five New Locations In and Around Chicago for the Summer of 2015 2
... trouble finding that perfect,holiday gift? Maybe it,s time ... a healthier smile. , , ... , , Registered ... free and unrestricted use at http://www.mediaseed.tv . , ...
... China,s leading,research, consulting and IT outsourcing service provider, and ... Kong Stock Exchange:,HK08235), recently released its article on China,s ... In 2007, the rapid development of the ... in turn drove the development of medical insurance,policies. Benefiting ...
... Serving as a model for public health action on vitamin D, GrassrootsHealth, ... scientists, institutions and individuals committed to solving the worldwide vitamin D deficiency ... for health professionals at UC San Diego, December 2 from 8 a.m. ... ...
... other household members may be the most effective way of ... say a group of paediatric intensive care doctors on ... infectious disease which affects infants and young children. Vaccination is ... four months of age, with a further booster after three ...
... the presence of disinfecting solutions , , THURSDAY, Nov. 27 (HealthDay ... say Israeli researchers who found at least one pathogen in ... The tests of contact lens disinfection solution in the storage ... of severe corneal infections -- was the most common type ...
... from end-stage renal disease (ESRD), a growing number of ... (CHUM), have become the beneficiaries of a North American ... blood purification technique, HDF is indicated for ESRD patients. ... section, preliminary results show a clear advantage of high ...
Cached Medicine News:Health News:CCID Consulting Discusses China's Medical Equipment Market 2Health News:CCID Consulting Discusses China's Medical Equipment Market 3Health News:CCID Consulting Discusses China's Medical Equipment Market 4Health News:CCID Consulting Discusses China's Medical Equipment Market 5Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 3Health News:Parents of new babies should be considered for a whooping cough booster, say experts 2Health News:Contact Lens Cases Often Contaminated 2Health News:Major North American breakthrough for dialysis patients 2Health News:Major North American breakthrough for dialysis patients 3
(Date:3/3/2015)... , March 3, 2015  HeartIT is ... the first Cardiac Magnetic Resonance Solution in the ... within a standard web browser. Precession™ combines zero ... features unmatched in the industry. This provides CMR ... all the critical functions of a successful CMR ...
(Date:3/3/2015)... NEWARK, Calif. , March 3, 2015 Depomed, ... will be presenting at the 27 th Annual Roth ... presentation is scheduled for 12:30 pm ET (9:30 am PT) ... webcast, and the webcast can be accessed via the Investor ... A recording of the webcast will be archived for 30 ...
(Date:3/3/2015)... March 3, 2015  MabVax Therapeutics (OTCQB: MBVX), a cancer ... , the Company,s President and CEO, will be presenting at ... March 9 – 12, 2015 at the Ritz Carlton in ... MabVax,s presentation is scheduled for Wednesday, March 11 th , ... for review on the Investor Relations section of the Company,s ...
Breaking Medicine Technology:Precession Advances Medical Imaging by Delivering a Complete Cardiac Magnetic Resonance Platform in a Web Browser 2Depomed To Present At 27th Annual Roth Conference 2
... 25 BiPar Sciences, Inc., a,privately held biopharmaceutical ... has hired industry veterans Eric D. Malek as ... as vice president,for regulatory affairs. "Over the ... role in clinical,stage product partnerships involving major pharmaceutical ...
... ARBOR, Mich. Sept. 24 Velcura Therapeutics, Inc., ... with the,U.S. Food and Drug Administration (FDA) Sept. ... of VEL-0230, a drug developed to treat bone,disease. ... (IND),meeting was to obtain feedback from the FDA,s ...
Cached Medicine Technology:BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer 2Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease 2Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease 3
... glucuronide (3alpha-diol G) is the glucuronide ... of dihydrotestosterone (DHT) [1,2]. 3alpha-diol G ... 75% of the bioactivity of testosterone ... product of intracellular reduction of DHT, ...
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... Gla protein, is a vitamin K-dependent, calcium ... of the noncollagenous bone matrix [1,2,3]. Osteocalcin ... a small amount produced by odontoblasts in ... formation, newly synthesized osteocalcin is incorporated into ...
... binding protein-2 (IGFBP-2) is one of six ... which specifically bind and modulate the actions ... of IGFBP-2 for IGF-II is estimated to ... suggesting a role in regulation of IGF-II ...
Medicine Products: